skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8830

A novel cell-based 384-well, label-free assay for discovery of inhibitors of influenza A virus

Other

(1712) Views  (987) Full article downloads

Authors: Fuli Jia, Clinton Maddox, Alice Gao, et al

Published Date May 2010 Volume 2010:1 Pages 57 - 67
DOI: http://dx.doi.org/10.2147/IJHTS.S8893

Fuli Jia1, Clinton Maddox2, Alice Gao3, Louie Tran3, William Severson1, E Lucile White2, Lynn Rasmussen2, Anju Dang3, Colleen B Jonsson1,4

1Department of Biochemistry and Molecular Biology, Southern Research Institute, Birmingham, AL, USA; 2High-Throughput Screening Center, Southern Research Institute, Birmingham, AL, USA; 3Corning Life Science, Corning, NY, USA; 4Department of Microbiology and Immunology, University of Louisville, Louisville, KY, USA

Abstract: Resonance wave-guide (RWG) biosensor technology allows label-free measurements of global cellular responses of the dynamic mass redistribution (DMR). We hypothesized that the DMR signals to extracellular stimulations occurring upon entry of a virus, could provide a new approach for the development of physiologically relevant cell-based assays for screening of small molecules. We explored this technology with influenza virus (A/Udorn/72, H3N2) using MDCK and Vero E6 cell lines in a 384-well format. The MDCK cell line assay was optimized with a fibronectin-coated surface microplate with 6000 cells per well that were infected at a multiplicity of infection (MOI) of 1. Under this set of optimized conditions, for the vero E6 cells, an assay window of 1130 pm shift were obtained at 24 hours. The Vero E6 cell line assay was optimized using a poly-D-lysine-coated surface with seeding density of 6000 cells per well that were infected at a MOI of 5. Under this set of optimized conditions for the MDCK cells, an assay window of >600 units and Z values of 0.6–0.7 were obtained at 24 h. A small library of 1120 compounds was screened using the MDCK, which demonstrates the feasibility of the approach for high-throughput screening.

Keywords: small molecule screening, label-free technology, antivirals








Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Finding a new drug and vaccine for emerging swine flu: What is the concept?
Open access liquid chromatography/tandem mass spectrometry: implementation of a fully quantitative system in a drug discovery laboratory
Computational characterization of SAR microenvironments in high-throughput screening data
Development of a functional HTS assay for the APJ receptor
Development of a high throughput screening assay for inhibitors of hedgehog-heparin interactions
New developments and emerging trends in high-throughput screening methods for lead compound identification
Cardiometabolic results from an armband-based weight loss trial
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio